We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Cytokine Blocks Immune System's Cancer Defense

By Biotechdaily staff writers
Posted on 05 Dec 2002
Researchers have uncovered the mechanism of immune evasion by which Kaposi's sarcoma-associated herpes virus (KSHV) avoids the body's immune response and promotes the development of cancer cells. More...
Their findings were reported in the November 15, 2002, issue of Science.

The investigators, from the University of Pittsburgh Cancer Institute (PA, USA; www.pitt.edu), examined the expression of a virus-derived cytokine in KSHV. They found that this cytokine, viral IL-6 (vIL-6), not only inhibited immune function but also caused cancerous cells to grow. This comes about because during viral infection, host cells induce the antiviral factor interferon (IFN) to up-regulate the p21 gene, initiate cell cycle arrest, and inhibit virus replication but viral IL-6 blocks IFN signaling.

"The importance of this finding is that it demonstrates there is an overlap between the immune system and tumor suppressor pathways that are targeted by KSHV,” explained Dr. Patrick S. Moore, director of the molecular virology program at the University of Pittsburgh Cancer Institute. "It further demonstrates that viruses which inhibit immune functions also can, under some circumstances, induce tumor cells to grow because these viruses are attacking pathways that are important in both immunity and suppression of tumor growth.”




Related Links:
University of Pittsburgh Medical Center

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
Food Allergy Screening ELISA Kit
Allerquant 14G B ELISA
Manual Pipetting Aid
Pipette Controllers macro
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Alzheimer’s pathology can start 15 to 20 years before symptoms, and validated tools that reach patients earlier help pave the way for earlier detection. (Image Credit: Adobe Stock)

Alzheimer’s Blood Test Becomes First FDA-Cleared Option for Adults as Young as 40

C2N Diagnostics’ PrecivityAD2 blood test was cleared by the U.S. Food and Drug Administration (FDA) on August 20, 2026, for adults as young as 40 who are experiencing signs of cognitive impairment, according... Read more

Pathology

view channel
Image: Adrenal gland tumor stained with hematoxylin and eosin (top) and CYP11B2 (bottom) (Photo courtesy of Christofer Juhlin)

Simple Immunohistochemical Size Ratio Improves Classification of Primary Aldosteronism

Primary aldosteronism is a common but underdiagnosed cause of hypertension, in which excess aldosterone promotes salt retention and raises blood pressure. Identifying the dominant source of hormone overproduction... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.